Abstract
Our previous studies demonstrated that Qi-Shao-Shuang-Gan (QSSG), a combination of Astragalus membranaceus saponins (SAM) with Paeonia lactiflora glycosides (GPL), possessed protective effects against sepsis in mice. The present study aimed to explore its underlying mechanisms with a focus on the adhesion between leukocytes and inflammatory endothelial cells. Our results showed that QSSG (10, 30, 100 μg/ml) concentration-dependently inhibited the adhesion between leukocytes and lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVECs), and downregulated the expressions of endothelial adhesion molecules such as E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in HUVECs. It also suppresssed the phosphorylations of JNK, ERK and p38 MAPK, as well as the activation of NF-κB in HUVECs. The findings revealed that QSSG was able to prevent the adhesion between leukocytes and endothelial cells, which supported a plausible explanation for the antiseptic effects of QSSG.
Keywords: QSSG, adhesion, adhesion molecules, antiseptic effect, endothelial cells, leukocytes.
Current Signal Transduction Therapy
Title:Qi-Shao-Shuang-Gan Prevents Adhesion between Leukocytes and Inflammatory Endothelial Cells
Volume: 8 Issue: 2
Author(s): Xinghua Gao, Difei Bian, Xianxiang Xu, Rong Pan, Yufeng Xia, Side Jiang and Yue Dai
Affiliation:
Keywords: QSSG, adhesion, adhesion molecules, antiseptic effect, endothelial cells, leukocytes.
Abstract: Our previous studies demonstrated that Qi-Shao-Shuang-Gan (QSSG), a combination of Astragalus membranaceus saponins (SAM) with Paeonia lactiflora glycosides (GPL), possessed protective effects against sepsis in mice. The present study aimed to explore its underlying mechanisms with a focus on the adhesion between leukocytes and inflammatory endothelial cells. Our results showed that QSSG (10, 30, 100 μg/ml) concentration-dependently inhibited the adhesion between leukocytes and lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVECs), and downregulated the expressions of endothelial adhesion molecules such as E-selectin, P-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in HUVECs. It also suppresssed the phosphorylations of JNK, ERK and p38 MAPK, as well as the activation of NF-κB in HUVECs. The findings revealed that QSSG was able to prevent the adhesion between leukocytes and endothelial cells, which supported a plausible explanation for the antiseptic effects of QSSG.
Export Options
About this article
Cite this article as:
Gao Xinghua, Bian Difei, Xu Xianxiang, Pan Rong, Xia Yufeng, Jiang Side and Dai Yue, Qi-Shao-Shuang-Gan Prevents Adhesion between Leukocytes and Inflammatory Endothelial Cells, Current Signal Transduction Therapy 2013; 8 (2) . https://dx.doi.org/10.2174/15743624113089990002
DOI https://dx.doi.org/10.2174/15743624113089990002 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Correlation between Serum 25 hydroxy vitamin D level and plasminogen activator inhibitor 1 in type 2 diabetic patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Remote Ischemic Conditioning Improves Cognitive Function During Cerebral Vascular Injury Through the Induction of Autophagy
Current Neurovascular Research Mononuclear Cell Recruitment and Inflammation in Atherosclerosis
Vascular Disease Prevention (Discontinued) The Effects of Antihypertensive Therapy on Haemostatic Parameters
Current Pharmaceutical Design Emerging Trends and their Impacts on Peptic Ulcer Diseases: Treatments and Techniques
Current Drug Therapy Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters Effects of Lipid-Lowering Agents on Inflammation, Haemostasis and Blood Pressure
Current Pharmaceutical Design Recent Developments in Thrombin-Activatable Fibrinolysis Inhibitor Research
Mini-Reviews in Medicinal Chemistry Chitosan Applications on Pharmaceutical Sciences: A Review
Drug Delivery Letters Hyaluronic Acid/Parecoxib-Loaded PLGA Microspheres for Therapy of Temporomandibular Disorders
Current Drug Delivery From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Current Pharmaceutical Design Progress in the Use of Autologous Regenerative Platelet-based Therapies in Implant Dentistry
Current Pharmaceutical Biotechnology Markers of Systemic Inflammation in Obstructive Sleep Apnea Syndrome
Current Respiratory Medicine Reviews The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews Editorial (Hot Topic: The First Theme Issue on PPARs for Brain Disorders)
Current Drug Targets Host Immune Responses to Aeromonas Virulence Factors
Current Immunology Reviews (Discontinued) Simultaneous Genotyping of Four Single Nucleotide Polymorphisms Associated with Risk Factors of Hemostasis Disorders
Combinatorial Chemistry & High Throughput Screening How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Current Pharmaceutical Design